Life Changing Daily Pill that Fights Cancer and Autoimmune Diseases
Invest Now for a Limited Time

Meet Our Cofounders and Advisors

Trethera was founded by globally recognized UCLA faculty and is advised by  science and business leaders.
Owen Witte, MD

Owen Witte, MD

UCLA; Trethera cofounder; Discovered the BTK gene; Formerly Kite Pharma board director.

Michael Shepard, PHD

Michael Shepard, PHD

Formerly Genentech; Invented Herceptin; Distinguished Scientist and Lasker Laureate.

Caius Radu, MD

Caius Radu, MD

UCLA; Trethera cofounder; Global authority regarding nucleotide metabolism pathways.

Larry Steinman, MD

Larry Steinman, MD

Stanford; Discovered Tysabri; Won Dystel and Charcot Prizes for MS research.

Frank Baxter

Frank Baxter

Formerly Jefferies bank Chairman and CEO; NASDAQ stock exchange director; US ambassador.

Mike Jung, PhD

Mike Jung, PhD

UCLA; Trethera cofounder; Discovered approved prostate cancer drugs Erleada and Xtandi.

Rick Morrisey, PHD

Rick Morrisey, PHD

Formerly Celgene Preclinical Development Head; President, American Board of Toxicology.

Michael Levy, MD, PHD

Michael Levy, MD, PHD

Harvard; Distinguished expert in rare neurologic diseases and neuroimmunology.

Peter Clark, PHD

Peter Clark, PHD

UCLA; Noted nucleotide metabolism preclinical researcher focused on autoimmune diseases.

David Nathanson, PHD

David Nathanson, PHD

UCLA; Trethera cofounder; Neuroscience and Comprehensive Cancer Programs.

Johannes Czerin, MD

Johannes Czerin, MD

UCLA; Trethera cofounder; Nuclear Medicine and Translational Theranostics.

Ben Greenberg, MD

Ben Greenberg, MD

UT Southwestern; Distinguished neurologist specialized in rare autoimmune disorders.